CD38 and melanoma: A study found that untreated control mice formed well vascularized tumors and developed lung metastasis compared with melanoma-infected mice treated with the NAADP inhibitor Ned-19, suggesting that targeted CD38 inhibition in melanoma is partly caused by reduced NAADP production (47).